Kevin Feeley - 07 Jan 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
07 Jan 2025
Net transactions value
-$2,964,859
Form type
4
Filing time
10 Jan 2025, 17:54:33 UTC
Previous filing
06 Jan 2025
Next filing
31 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise $366,165 +11,208 +42% $32.67 37,978 07 Jan 2025 Direct
transaction WGS Class A Common Stock Sale $2,246,478 -24,073 -63% $93.32 13,905 07 Jan 2025 Direct F1, F2
transaction WGS Class A Common Stock Sale $667,307 -7,078 -51% $94.28 6,827 07 Jan 2025 Direct F1, F3
transaction WGS Class A Common Stock Sale $330,371 -3,455 -51% $95.62 3,372 07 Jan 2025 Direct F1, F4
transaction WGS Class A Common Stock Sale $86,868 -900 -27% $96.52 2,472 07 Jan 2025 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Employee Stock Option (Right to Buy) Options Exercise $0 -11,208 -56% $0.000000 8,719 07 Jan 2025 Common Stock 11,208 $32.67 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.99 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.06 to $96.01 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.15 to $96.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The stock option vested and is exercisable as 6.25% vest in quarterly installments over the 4-year period commencing on December 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date